tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market

Medicamen Biotech Limited (MEDICAMEQ) Income Statement

Compare
0 Followers

Medicamen Biotech Limited Income Statement

Last quarter (Q1 2026), Medicamen Biotech Limited's total revenue was ₹430.45M, a decrease of >-0.01% from the same quarter last year. In Q1, Medicamen Biotech Limited's net income was ₹21.53M. See Medicamen Biotech Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 1.63B₹ 1.79B₹ 1.41B₹ 1.15B₹ 1.13B
Gross Profit
₹ 389.90M₹ 852.01M₹ 687.74M₹ 479.88M₹ 335.16M
Operating Expenses
₹ 321.98M₹ 335.17M₹ 91.99M₹ 289.89M₹ 160.41M
Depreciation and Amortization
₹ 70.66M₹ 70.93M₹ 72.75M₹ 57.71M₹ 25.20M
EBITDA
₹ 201.02M₹ 245.66M₹ 277.12M₹ 258.07M₹ 204.25M
Operating Income
₹ 67.92M₹ 516.84M₹ 182.46M₹ 187.07M₹ 174.96M
Other Income/Expenses
₹ 30.88M₹ -386.09M₹ -12.01M₹ -6.12M₹ -11.02M
Pretax Income
₹ 98.80M₹ 130.76M₹ 170.45M₹ 180.94M₹ 163.94M
Net Income
₹ 71.08M₹ 109.31M₹ 148.44M₹ 148.98M₹ 121.29M
Per Share Metrics
Basic EPS
₹ 5.59₹ 8.63₹ 11.73₹ 12.19₹ 9.93
Diluted EPS
₹ 5.59₹ 8.63₹ 11.73₹ 12.19₹ 9.93
Weighted Average Shares Outstanding
12.70M 12.66M 12.46M 12.22M 12.22M
Weighted Average Shares Outstanding (Diluted)
12.70M 12.66M 12.46M 12.22M 12.22M
Currency in INR

Medicamen Biotech Limited Earnings and Revenue History